Advarra OnCore vs. emocha Health

Overview
ProductRatingMost Used ByProduct SummaryStarting Price
Advarra OnCore
Score 4.0 out of 10
N/A
OnCore, from Advarra in Columbia (formerly known as Forte Research Systems) provides automated clinical research support featuring, billing and financial management, specimen management, reporting, effort tracking, and integration into other clinical systems.N/A
emocha Health
Score 0.0 out of 10
N/A
emocha uses video technology and human engagement to empower patients to take every dose of medication as prescribed. emocha facilitates a daily touchpoint for patients in order to expand access to treatment, extend the reach of existing care teams, and retain patients in care. emocha’s turnkey, enterprise adherence solution operates through dose-by-dose observation and clinical assessment of potential administration problems, including technique and side effects. Coupled with daily engagement,…N/A
Pricing
Advarra OnCoreemocha Health
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
Advarra OnCoreemocha Health
Free Trial
NoNo
Free/Freemium Version
NoNo
Premium Consulting/Integration Services
NoNo
Entry-level Setup FeeNo setup feeNo setup fee
Additional Details
More Pricing Information
Community Pulse
Advarra OnCoreemocha Health
User Ratings
Advarra OnCoreemocha Health
Likelihood to Recommend
9.0
(0 ratings)
-
(0 ratings)
User Testimonials
Advarra OnCoreemocha Health
Likelihood to Recommend
Advarra is well suited for monitoring the progress of the clinical trials for a research organization. It's biggest advantage is the fact that the participants details and accrual monitoring shows the progress of the clinical trial. OnCore provides the capability of creating and using study calendars and especially monitoring and tracking participants visits. OnCore may be less appropriate to use in regards to grants and funds tracking.
Read full review
No answers on this topic
Alternatives Considered
I have not used nor evaluated any other products similar to Advarra OnCore. Did not participate in the selection process.
Read full review
No answers on this topic
ScreenShots